Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
09 August 2018Website:
http://www.vaccinex.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 25 min agoDividend
Analysts recommendations
Institutional Ownership
VCNX Latest News
Company expects to lock database in June andremains on track to report key outcomes later in July. Pepinemab targets astrocyte reactivity and neuroinflammation,believed to be key drivers of neurodegeneration.
Final patient completed their last visit in the SIGNAL-AD Phase 2a trial evaluating pepinemab for Alzheimer's Disease in early June 2024. $8.2 million of fresh funding was secured in the first quarter.
Vaccinex (NASDAQ: VCNX ) stock is climbing higher on Friday after the clinical-stage biotechnology company announced insider buying. These insider trading actions were revealed by Vaccinex in a series of filings with the Securities and Exchange Commission (SEC).
Fintel reports that Fcmi Parent has filed a 13D/A form with the SEC disclosing ownership of 23.49MM shares of Vaccinex Inc (VCNX).
What type of business is Vaccinex?
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.
What sector is Vaccinex in?
Vaccinex is in the Healthcare sector
What industry is Vaccinex in?
Vaccinex is in the Biotechnology industry
What country is Vaccinex from?
Vaccinex is headquartered in United States
When did Vaccinex go public?
Vaccinex initial public offering (IPO) was on 09 August 2018
What is Vaccinex website?
https://www.vaccinex.com
Is Vaccinex in the S&P 500?
No, Vaccinex is not included in the S&P 500 index
Is Vaccinex in the NASDAQ 100?
No, Vaccinex is not included in the NASDAQ 100 index
Is Vaccinex in the Dow Jones?
No, Vaccinex is not included in the Dow Jones index
When does Vaccinex report earnings?
The next expected earnings date for Vaccinex is 14 August 2024